Cargando…
Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
Autor principal: | Riddle, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747890/ https://www.ncbi.nlm.nih.gov/pubmed/23970714 http://dx.doi.org/10.2337/dc13-1019 |
Ejemplares similares
-
The regulation of learning in clinical environments: A comment on ‘Beyond the self’
por: Nieboer, Patrick, et al.
Publicado: (2020) -
Medical learning: From clinical-to-tech-based thinking (beyond typical clinical signs)
por: Mohammad, Ameen M.
Publicado: (2021) -
Procalcitonin beyond the acute phase: novel biomediator properties?
por: Panico, Carolina, et al.
Publicado: (2013) -
A Commentary on “Medical learning: From clinical-to-tech-based thinking (beyond typical clinical signs)”
por: Ascencio-Vera, María Gabriela, et al.
Publicado: (2021) -
TSLP‐targeting therapy: Beyond allergy?
por: Ebina‐Shibuya, Risa, et al.
Publicado: (2023)